IPC provides training to 30 participants to develop effective & sustainable PV practices for WHO-PIDM member countries
In order to develop effective and sustainable
pharmacovigilance practices for member countries of the WHO Programme for
International Drug Monitoring (WHO-PIDM), the Indian Pharmacopoeia Commission
(IPC) has trained 30 participants from countries like Sweden, Zimbabwe, Malawi,
Congo, Swaziland, Bangladesh, Vietnam, Maldives, Botswana, Oman, Philippines,
Malaysia, Ethiopia and India to build capacity in pharmacovigilance (PV) for
promoting safe use of medicines.
The training programme, 5th Asia Pacific Pharmacovigilance
Training Course which recently concluded, was aimed at integrating the public
health programmes of member countries with PV activities towards drug safety.
The training was well received as the participants were
acquainted on basic knowledge and understanding the concept of
pharmacovigilance. Overall this training programme will be useful in
strengthening pharmacovigilance activity at their respective
organizations/countries in order to protect the safety and well being of the
patients.
The international pharmacovigilance experts from WHO, WHO
Collaborating Centres, MHRA, UMC, Drug Regulatory Authorities, academic
institutions, IPC and the pharmaceutical industries were part of the programme.
The training imparted was tailored to regional needs and
addressed challenges unique to PV. The purpose of the course is to further
develop effective and sustainable pharmacovigilance practices for member
countries of the WHO-PIDM and individuals involved in the field by creating a
unique opportunity for learning and collaboration.
Dr G N Singh, Secretary-cum-Scientific Director, IPC stressed
on the dire need of pharmacovigilance training and technical support to WHO
member countries besides ensuring sustainable pharmacovigilance development in
India. The programme is very relevant and important as IPC got the active
support of Uppsala Monitoring Centre (UMC), Sweden, he added.
IPC has been assigned to update information on ADR data that
is being reported in India from across all its centres through Vigiflow
software to the UMC in Sweden, which is WHO's collaborating centre for
international drug monitoring.
As a part of its initiatives in PV, IPC has designed a road
map to support South East Asia Regulatory Network (SEARN) nation countries
towards integrating their public health programmes with PV for drug safety.
UMC was the first WHO Collaborating Centre to be established
for PV when, in 1978, the scientific and technical responsibility of the WHO
programme for international drug monitoring was transferred to Sweden.
Clinical trial management is the focus area of the job, where management of all sorts of activities related to clinical research and trials are carried out. Here mainly the documentation part and the reporting part is handled with care, and full precautions in order to minimize the errors while recording and submitting the documents to the apex body.
ReplyDeletepharmacovigilance courses in pune
Diploma in pharmacovigilance course in pune
clinical data management course in pune
This blog is definitely interesting additionally informative. I have picked up many useful tips out of this source. I ad love to come back again soon. Thanks a lot! for More Details Click Here: Clinical Research Courses with 100% Placement
ReplyDeleteThis post is good and fruitful in support of all new Pharmacovigilance Courses Online related services & must study it.
ReplyDelete